Showing results (1051-1060 of 12,114) with videos related to
Sort By:
Pageof 1,212
Neuropharmacology|December 10, 1999
Pertussis toxin decreases absence seizures and GABA(B) receptor binding in thalamus of a genetically prone rat (GAERS)N G Bowery, K Parry, A Boehrer, et al.Neuropharmacology|December 10, 1999
Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampusS R Cobb, N A Manuel, R A Morton, et al.Neuropharmacology|December 10, 1999
GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitroR A DeiszNeuropharmacology|June 16, 2000
LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemiaM J O'Neill, L Bogaert, C A Hicks, et al.Neuropharmacology|June 16, 2000
The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572A Gobert, A Dekeyne, M J MillanNeuropharmacology|June 16, 2000
The dopamine antagonist sch 23390 reverses dizocilpine-induced blockade of cocaine sensitizationA Parada, P Soares-da-SilvaNeuropharmacology|June 16, 2000
The role of cytokines and prostaglandin-E(2) in thymulin induced hyperalgesiaB Safieh-Garabedian, M Dardenne, S A Kanaan, et al.Neuropharmacology|November 15, 2000
Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1J N Kew, J M Ducarre, M C Pflimlin, et al.Neuropharmacology|November 15, 2000
Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brainE O'Shea, B Esteban, J Camarero, et al.Neuropharmacology|November 15, 2000
125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptorsJ Higelin, G Py-Lang, C Paternoster, et al.Pageof 1,212